Concepedia
Statistics
Publications
16
Citations
1.1K
H-Index
Active since
2003
Affiliations
UCB Pharma (Belgium)(Current)
University of Amsterdam
Imperial College London
Amsterdam University Medical Centers
GlaxoSmithKline (United Kingdom)
Jonathan van Eyll is an author at UCB Pharma (Belgium) specializing in life sciences, neuroscience, and molecular biology.
Publications per year
2003–2024
IL-17–high asthma with features of a psoriasis immunophenotype
Jörgen Östling, Marleen van Geest, James Schofield et al. · Journal of Allergy and Clinical Immunology · 2019 · 137 citations · Full text
Life Sciences, Dermatology, Immunology +14
Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy
Manuela Mazzuferi, Gaurav Kumar, Jonathan van Eyll et al. · Annals of Neurology · 2013 · 134 citations
Life Sciences, Molecular Biology, Neuroscience +13
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
Prashant K. Srivastava, Jonathan van Eyll, Patrice Godard et al. · Nature Communications · 2018 · 106 citations · Full text
Pharmacy, Neuroscience, Systems Biology +13
Pathway analysis from lists of microRNAs: common pitfalls and alternative strategy
Patrice Godard, Jonathan van Eyll · Nucleic Acids Research · 2015 · 92 citations · Full text
Life Sciences, Bioinformatics, Molecular Biology +12
Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy
Till S. Zimmer, Bastian David, Diede W. M. Broekaart et al. · Acta Neuropathologica · 2021 · 89 citations · Full text
Medicine, Neurology, Neuroscience +15
1–5 of 16